|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/24 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 37/00 | (2006.01) |
| (11) | Number of the document | 2931313 |
| (13) | Kind of document | T |
| (96) | European patent application number | 13863590.9 |
| Date of filing the European patent application | 2013-12-09 | |
| (97) | Date of publication of the European application | 2015-10-21 |
| (45) | Date of publication and mention of the grant of the patent | 2019-05-08 |
| (46) | Date of publication of the claims translation | 2019-09-25 |
| (86) | Number | PCT/US2013/073825 |
| Date | 2013-12-09 |
| (87) | Number | WO 2014/093203 |
| Date | 2014-06-19 |
| (30) | Number | Date | Country code |
| 201261737035 P | 2012-12-13 | US |
| (72) |
KASHI, Ramesh, S., US
BADKAR, Aniket, US
|
| (73) |
Merck Sharp & Dohme LLC,
126 East Lincoln Avenue, Rahway, NJ 07065-0907,
US
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Genų inžinerijos būdu sukonstruotų antukūnų prieš IL-23P19 tirpalo formuluotės |
| SOLUTION FORMULATIONS OF ENGINEERED ANTI-IL-23P19 ANTIBODIES |
| Payment date | Validity (years) | Amount | |
| 2025-11-18 | 13 | 289.00 EUR |
| 2026-12-09 |